drugset / Trial / NCT02412319
The Clinical Trial of the Anti Hepatitis B Placenta Transfer Factor Injection
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Asses the efficacy and safety of the Anti hepatitis B placenta transfer factor injection in the treatment of HBeAg positive chronic hepatitis B.
Timeline
- Start
- 2014-10
- Primary completion
- 2016-12
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anti-HBV placenta transfer factor | Unknown | 2 mg | Intramuscular |